120 related articles for article (PubMed ID: 20600630)
1. Dissecting the transcriptional functions of human DNA topoisomerase I by selective inhibitors: implications for physiological and therapeutic modulation of enzyme activity.
Capranico G; Marinello J; Baranello L
Biochim Biophys Acta; 2010 Dec; 1806(2):240-50. PubMed ID: 20600630
[TBL] [Abstract][Full Text] [Related]
2. DNA topoisomerase I inhibition by camptothecin induces escape of RNA polymerase II from promoter-proximal pause site, antisense transcription and histone acetylation at the human HIF-1alpha gene locus.
Baranello L; Bertozzi D; Fogli MV; Pommier Y; Capranico G
Nucleic Acids Res; 2010 Jan; 38(1):159-71. PubMed ID: 19854946
[TBL] [Abstract][Full Text] [Related]
3. The effects of camptothecin on RNA polymerase II transcription: roles of DNA topoisomerase I.
Capranico G; Ferri F; Fogli MV; Russo A; Lotito L; Baranello L
Biochimie; 2007 Apr; 89(4):482-9. PubMed ID: 17336444
[TBL] [Abstract][Full Text] [Related]
4. Elongation by RNA polymerase II on chromatin templates requires topoisomerase activity.
Mondal N; Zhang Y; Jonsson Z; Dhar SK; Kannapiran M; Parvin JD
Nucleic Acids Res; 2003 Sep; 31(17):5016-24. PubMed ID: 12930951
[TBL] [Abstract][Full Text] [Related]
5. Antisense transcripts enhanced by camptothecin at divergent CpG-island promoters associated with bursts of topoisomerase I-DNA cleavage complex and R-loop formation.
Marinello J; Chillemi G; Bueno S; Manzo SG; Capranico G
Nucleic Acids Res; 2013 Dec; 41(22):10110-23. PubMed ID: 23999093
[TBL] [Abstract][Full Text] [Related]
6. The natural inhibitor of DNA topoisomerase I, camptothecin, modulates HIF-1α activity by changing miR expression patterns in human cancer cells.
Bertozzi D; Marinello J; Manzo SG; Fornari F; Gramantieri L; Capranico G
Mol Cancer Ther; 2014 Jan; 13(1):239-48. PubMed ID: 24252850
[TBL] [Abstract][Full Text] [Related]
7. Nascent DNA Proteomics Reveals a Chromatin Remodeler Required for Topoisomerase I Loading at Replication Forks.
Ribeyre C; Zellweger R; Chauvin M; Bec N; Larroque C; Lopes M; Constantinou A
Cell Rep; 2016 Apr; 15(2):300-9. PubMed ID: 27050524
[TBL] [Abstract][Full Text] [Related]
8. Early effects of topoisomerase I inhibition on RNA polymerase II along transcribed genes in human cells.
Khobta A; Ferri F; Lotito L; Montecucco A; Rossi R; Capranico G
J Mol Biol; 2006 Mar; 357(1):127-38. PubMed ID: 16427078
[TBL] [Abstract][Full Text] [Related]
9. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes.
Zhang H; Wang JC; Liu LF
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1060-4. PubMed ID: 2829214
[TBL] [Abstract][Full Text] [Related]
10. Hyperphosphorylation of RNA polymerase II in response to topoisomerase I cleavage complexes and its association with transcription- and BRCA1-dependent degradation of topoisomerase I.
Sordet O; Larochelle S; Nicolas E; Stevens EV; Zhang C; Shokat KM; Fisher RP; Pommier Y
J Mol Biol; 2008 Sep; 381(3):540-9. PubMed ID: 18588899
[TBL] [Abstract][Full Text] [Related]
11. Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription.
Bendixen C; Thomsen B; Alsner J; Westergaard O
Biochemistry; 1990 Jun; 29(23):5613-9. PubMed ID: 1696837
[TBL] [Abstract][Full Text] [Related]
12. Dynamic Effects of Topoisomerase I Inhibition on R-Loops and Short Transcripts at Active Promoters.
Marinello J; Bertoncini S; Aloisi I; Cristini A; Malagoli Tagliazucchi G; Forcato M; Sordet O; Capranico G
PLoS One; 2016; 11(1):e0147053. PubMed ID: 26784695
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation.
Rialdi A; Campisi L; Zhao N; Lagda AC; Pietzsch C; Ho JSY; Martinez-Gil L; Fenouil R; Chen X; Edwards M; Metreveli G; Jordan S; Peralta Z; Munoz-Fontela C; Bouvier N; Merad M; Jin J; Weirauch M; Heinz S; Benner C; van Bakel H; Basler C; García-Sastre A; Bukreyev A; Marazzi I
Science; 2016 May; 352(6289):aad7993. PubMed ID: 27127234
[TBL] [Abstract][Full Text] [Related]
14. Evodiamine, a dual catalytic inhibitor of type I and II topoisomerases, exhibits enhanced inhibition against camptothecin resistant cells.
Pan X; Hartley JM; Hartley JA; White KN; Wang Z; Bligh SW
Phytomedicine; 2012 May; 19(7):618-24. PubMed ID: 22402246
[TBL] [Abstract][Full Text] [Related]
15. Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction.
Wu Y; Wang KY; Li Z; Liu YP; Izumi H; Uramoto H; Nakayama Y; Ito K; Kohno K
J Exp Clin Cancer Res; 2014 Dec; 33(1):112. PubMed ID: 25539742
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional consequences of topoisomerase inhibition.
Collins I; Weber A; Levens D
Mol Cell Biol; 2001 Dec; 21(24):8437-51. PubMed ID: 11713279
[TBL] [Abstract][Full Text] [Related]
17. UVC inhibits HIF-1alpha protein translation by a DNA damage- and topoisomerase I-independent pathway.
Rapisarda A; Melillo G
Oncogene; 2007 Oct; 26(48):6875-84. PubMed ID: 17496931
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the participation of topoisomerases I and II in cadmium-induced metallothionein expression in Chinese hamster ovary cells.
Mattern MR; Tan KB; Zimmerman JP; Mong SM; Bartus JO; Hofmann GA; Drake FH; Johnson RK; Crooke ST; Mirabelli CK
Anticancer Drug Des; 1989 Aug; 4(2):107-24. PubMed ID: 2478139
[TBL] [Abstract][Full Text] [Related]
19. Cell-based high-throughput compound screening reveals functional interaction between oncofetal HMGA2 and topoisomerase I.
Peter S; Yu H; Ivanyi-Nagy R; Dröge P
Nucleic Acids Res; 2016 Dec; 44(22):e162. PubMed ID: 27587582
[TBL] [Abstract][Full Text] [Related]
20. Role of DNA topoisomerase I in the transcription of supercoiled rRNA gene.
Garg LC; DiAngelo S; Jacob ST
Proc Natl Acad Sci U S A; 1987 May; 84(10):3185-8. PubMed ID: 3033639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
